CORRECTION article

Front. Physiol., 18 October 2019

Sec. Red Blood Cell Physiology

Volume 10 - 2019 | https://doi.org/10.3389/fphys.2019.01331

Corrigendum: The Spectrum of SPTA1-Associated Hereditary Spherocytosis

  • 1. Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States

  • 2. Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States

  • 3. College of Nursing, University of Cincinnati, Cincinnati, OH, United States

  • 4. Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States

  • 5. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States

  • 6. Duke University Medical Center, Durham, NC, United States

  • 7. Division of Hematology, CHOC Children's Hospital and UC Irvine Medical Center, Orange, CA, United States

  • 8. Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA, United States

  • 9. Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States

  • 10. Kaiser Permanente Santa Clara Medical Center, Santa Clara, CA, United States

  • 11. Dell Children's Medical Center, Austin, TX, United States

  • 12. Genomics Analysis Facility, Institute for Genomic Medicine, Columbia University, New York, NY, United States

  • 13. Coyote Bioscience Co., Ltd., San Jose, CA, United States

  • 14. Laboratory of Genetics and Genomics, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States

In the original article, there was a mistake in Table 1 as published. The SPTA1 mutation of Allele 2 in Patient 1, is stated as “c.4294T>A (p.L1432*).” The correct mutation should read “c.4295del (p.L1432*).” The corrected Table 1 appears below.

Table 1

PhenotypePatientAllele 1Allele 2Age at time of report and commentsEktacytometryα-spectrin in RBC ghosts (% of control)
GROUP I (patients 1–4) Severe, recessive HS (transfusion-dependent, responding to splenectomy)1c.4339-99C > Tc.4295del
(p.L1432*)
11 year-old, chronic transfusion requirement with partial response to partial splenectomy, resolved after total splenectomy54%
2c.4339-99C > Tc.5102A > T
(p.L1701*)
7 year-old, chronic transfusion requirement, improved with partial splenectomy64%
3c.4339-99C > Tc.3267A > T
(p.Y1089*)
11 year-old, not splenectomized due to family preference, continues to require frequent transfusionsNot evaluable in a transfused sample
4Mutation not identifiedGross deletion of SPTA13.5 year-old, RT-PCR demonstrated significantly decreased α-spectrin expression; hemoglobin has normalized after recent splenectomyNot evaluable in a transfused sample
GROUP II (patients 5–8) Severe to moderately severe, recessive HS5c.4339-99C > Tc.1120C > T
(p.R374*)
4 year-old, chronic transfusion requirement for first three years with improved pattern since.Sample not provided after age 3, when transfusion-independent
6c.4339-99C > Tc.1351-1G > T7 year-old, occasional transfusion requirement, resolved after splenectomy at 5 years of age59%
7c.4339-99C>Tc.2671C > T (p.R891*)4 year-old, has not been transfused so far, Hgb 7.1-8.9 g/dL, ARC 420-572 x 103/μl.61%
8c.4339-99C > Tc.3257delT8 year-old, transfused once as neonate, Hgb 10.6–11.8 g/dL, ARC 354–535 x 103/μl; now Hgb 15–16 g/dL with normal ARC after splenectomy at 6 years of age (splenectomy performed because of chronic abdominal pain due to co-morbidities)Not performed.
GROUP III (patients
9-11) Life-threatening anemia in utero leading to fatal hydrops fetalis if untreated (transfusion-dependent, not responding to splenectomy)
9c.4206delG (fs)c.4180delT (fs) in haplotype with c.6631C > T (p.R2211C)Died at birth. Post-mortem diagnosis from parental studies and DNA extracted from liver tissue saved in paraffin blockN/A
10c.6788+11C > Tc.6788+11C > T11 year-old, born prematurely at EGA of 33 weeks with hydrops fetalis, remained transfusion-dependent even after splenectomy; now doing well after matched sibling transplantNot evaluable in a transfused sample (required chronic transfusions up until bone marrow transplant)26% (performed in CD71+ cells)
11c.6154del
(p.Ala2052fs)
c.6154del
(p.Ala2052fs)
2 year-old, severe in-utero anemia requiring five in-utero transfusions. Born with severe neonatal hyperbilirubinemia requiring exchange transfusion. Remains transfusion-dependentNot evaluable in a transfused sample

Genetic mutations and associated phenotype in HS due to SPTA1 mutations.

Of note, all the SPTA1 variants reported here except c.4339-99C > T (αLEPRA) and c.2671C > T; p.R891

*

(Bogardus et al., 2014) have not been previously described.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

References

  • 1

    BogardusH.SchulzV. P.MaksimovaY.MillerB. A.LiP.ForgetB. G.et al. (2014). Severe nondominant hereditary spherocytosis due to uniparental isodisomy at the SPTA1 locus. Haematologica99, e168e170. 10.3324/haematol.2014.110312

Summary

Keywords

SPTA1, α-spectrin, αLEPRA, hereditary spherocytosis, next generation sequencing, hemolytic anemia, hydrops fetalis

Citation

Chonat S, Risinger M, Sakthivel H, Niss O, Rothman JA, Hsieh L, Chou ST, Kwiatkowski JL, Khandros E, Gorman MF, Wells DT, Maghathe T, Dagaonkar N, Seu KG, Zhang K, Zhang W and Kalfa TA (2019) Corrigendum: The Spectrum of SPTA1-Associated Hereditary Spherocytosis. Front. Physiol. 10:1331. doi: 10.3389/fphys.2019.01331

Received

03 September 2019

Accepted

04 October 2019

Published

18 October 2019

Volume

10 - 2019

Edited by

Paola Bianchi, IRCCS Ca 'Granda Foundation Maggiore Policlinico Hospital, Italy

Reviewed by

Elisa Fermo, IRCCS Ca 'Granda Foundation Maggiore Policlinico Hospital, Italy

Updates

Copyright

*Correspondence: Theodosia A. Kalfa

This article was submitted to Red Blood Cell Physiology, a section of the journal Frontiers in Physiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics